Synthesis and preliminary evaluation of [18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo

被引:22
作者
Zhang, MR
Tsuchiyama, A
Haradahira, T
Furutsuka, K
Yoshida, Y
Kida, T
Noguchi, J
Irie, T
Suzuki, K
机构
[1] Natl Inst Radiol Sci, Dept Med Imaging, Inage Ku, Chiba 2638555, Japan
[2] SHI Accelerator Serv Co Ltd, Shinagawa Ku, Tokyo 1418686, Japan
[3] Tokyo Univ Sci, Fac Pharmaceut Sci, Shinjuku Ku, Tokyo 1620014, Japan
[4] Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan
关键词
acetylcholinesterase; Alzheimer's disease; F-18]FEtBr; F-18]FEtP4A; PET;
D O I
10.1016/S0969-8051(01)00315-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
N-[F-18]Fluoroethyl-4-piperidyl acetate ([F-18]FEtNA), an analog of [C-11]MP4A for mapping brain acetylcholineseterase (AchE) activity, was prepared by reacting 4-piperidyl acetate (P4A) with [F-18]fluoroethyl bromide ([F-18]FEtBr) using a newly developed automated system. Preliminary evaluation showed that the initial uptake of [F-18]FF-tP4A in the mouse brain was > 8% injected dose/g tissue. The distribution pattern of [F-18]FEtP4A in the brain was striatum> cerebral cortex >cerebellum within 10-120 min post-injection, which reflected the distribution rank pattern of AchE activity in the brain. Moreover, chemical analysis of in vivo radioactive metabolites in the mouse brain indicated that 83% of [F-18]FEtP4A was hydrolyzed to N-[F-18]fluoroethyl-4-piperidinol ([F-18]FEtP4OH) after 1 min intravenous injection. From these results, [F-18]FEtP4A may become a promising PET tracer for mapping the AchE in vivo. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:463 / 468
页数:6
相关论文
共 27 条
[1]  
AKULA MR, 1999, J LABELLED CPD RA S1, V42, pS617
[2]   C-11 LABELING OF AN INHIBITOR OF ACETYLCHOLINESTERASE - [C-11] PHYSOSTIGMINE [J].
BONNOTLOURS, S ;
CROUZEL, C ;
PRENANT, C ;
HINNEN, F .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1993, 33 (04) :277-284
[3]   Synthesis and evaluation of 6-[11C]methoxy-3-[2-[l-(phenylmethyl)-4-piperidinyl]ethyl]-1,2-benzisoxazole as an in vivo radioligand for acetylcholinesterase [J].
Brown-Proctor, C ;
Snyder, SE ;
Sherman, PS ;
Kilbourn, MR .
NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (01) :99-103
[4]   Muscarinic cholinergic receptor measurements with [18F]FP-TZTP:: Control and competition studies [J].
Carson, RE ;
Kiesewetter, DO ;
Jagoda, E ;
Der, MG ;
Herscovitch, P ;
Eckelman, WC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (10) :1130-1142
[5]   A RAPID AND EFFICIENT METHOD FOR THE FLUOROALKYLATION OF AMINES AND AMIDES - DEVELOPMENT OF A METHOD SUITABLE FOR INCORPORATION OF THE SHORT-LIVED POSITRON EMITTING RADIONUCLIDE F-18 [J].
CHI, DY ;
KILBOURN, MR ;
KATZENELLENBOGEN, JA ;
WELCH, MJ .
JOURNAL OF ORGANIC CHEMISTRY, 1987, 52 (04) :658-664
[6]  
DAVIES P, 1976, LANCET, V2, P1403
[7]  
Irie T, 1996, J NUCL MED, V37, P649
[8]   DESIGN AND EVALUATION OF RADIOACTIVE ACETYLCHOLINE ANALOGS FOR MAPPING BRAIN ACETYLCHOLINESTERASE (ACHE) IN-VIVO [J].
IRIE, T ;
FUKUSHI, K ;
AKIMOTO, Y ;
TAMAGAMI, H ;
NOZAKI, T .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (06) :801-808
[9]   EVALUATION OF PHENYLMETHANESULFONYL FLUORIDE (PMSF) AS A TRACER CANDIDATE MAPPING ACETYLCHOLINESTERASE IN-VIVO [J].
IRIE, T ;
FUKUSHI, K ;
IYO, M .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (08) :991-992
[10]   Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease [J].
Iyo, M ;
Namba, H ;
Fukushi, K ;
Shinotoh, H ;
Nagatsuka, S ;
Suhara, T ;
Sudo, Y ;
Suzuki, K ;
Irie, T .
LANCET, 1997, 349 (9068) :1805-1809